Ceftriaxone Dosing for 33 kg Patient
For a 33 kg child, administer ceftriaxone 50-75 mg/kg/day, which equals 1650-2475 mg daily, typically given as 1650 mg (50 mg/kg) once daily or divided into 825 mg twice daily, depending on the infection type and severity.
Dosing by Clinical Indication
For Severe Infections (Meningitis, Sepsis, Complicated Intra-abdominal Infections)
- Standard dose: 50-75 mg/kg/day = 1650-2475 mg daily 1
- Meningitis specifically: 50 mg/kg every 12 hours (BD) = 1650 mg twice daily 2, 3
- Maximum: Do not exceed 2 g per dose 1
For bacterial meningitis, twice-daily dosing (50 mg/kg BD) achieves better early CSF target attainment than once-daily dosing, with 100% probability of target attainment at steady state for common pathogens (MIC 1 mg/L) 4. Once-daily dosing shows only 53% probability of target attainment in the first 24 hours versus 88% for twice-daily at steady state 4.
For Moderate Infections (Pneumonia, Dysentery, Typhoid)
- Pneumonia: 80 mg/kg/day = 2640 mg once daily (but cap at 2 g = 2000 mg) 2
- Dysentery: 50-80 mg/kg/day = 1650-2640 mg once daily (cap at 2 g) 2
- Typhoid: 80 mg/kg/day = 2640 mg once daily (cap at 2 g) for 5-7 days 2
For Mild-Moderate Infections (Otitis Media Complications, Sinusitis)
- Single dose option: 50 mg/kg = 1650 mg IM or IV once 5, 6
- Can switch to oral antibiotics after 24 hours if improved 5
Practical Administration
Route and infusion time:
- IV infusion over 30 minutes is standard 7
- 10-minute infusions are safe and feasible for doses ≥50 mg/kg in children, improving patient flow in ambulatory settings 8
- IM administration acceptable for single doses 1
Frequency considerations:
- Once-daily dosing: Convenient, adequate for most non-CNS infections
- Twice-daily dosing: Preferred for meningitis and severe sepsis to ensure early target attainment 4
Critical Adjustments
Renal impairment:
- No dose adjustment needed unless both severe renal AND hepatic dysfunction are present 7
- In combined dysfunction, do not exceed 2 g daily and monitor closely 7
Enhanced renal clearance:
- Patients with eGFR >80 mL/min/1.73 m² may benefit from 50 mg/kg twice daily rather than once daily to improve target attainment, especially for less-susceptible pathogens (MIC ≥0.5 mg/L) 9
Important Caveats
Contraindications:
- Do NOT use in hyperbilirubinemic neonates (not applicable to 33 kg child) 7
- Avoid calcium-containing IV solutions 7
Monitoring requirements:
- Ensure adequate hydration to prevent urolithiasis 7
- Monitor for gallbladder pseudolithiasis (appears as sludge on ultrasound, reversible upon discontinuation) 7
- Watch for signs of pancreatitis, particularly in severely ill patients 7
Duration:
- Meningitis: 7-10 days for meningococcal, 10-14 days for pneumococcal 2, 3
- Sepsis: 7-10 days 2
- Pneumonia: At least 5 days 2
- Most other infections: 5-7 days 2
Resistance considerations: